期刊文献+

永久性心脏起搏器植入术后感染患者的护理

原文传递
导出
摘要 目的:优质护理对改善永久性心脏起搏器植入术后感染患者的应用效果探析。方法:选取2015年7月~2016年7月收治的60例安置永久性心脏起搏器患者为研究对象,随机分为两组,每组各30例,给予常规组患者实施常规护理,给予实验组实行围术期的优质护理。术后,对比两组的护理效果。结果:常规组患者总有效率为70%,实验组总有效率为70%。对比两组患者护理效果,差异显著(P<0.05);两组患者在植入起搏器后均发生了并发症,常规组30例患者中,电极脱位患者为7例,占23.33%、起搏器干扰患者为2例,占6.67%、电极导线断裂患者为3例,占10%,并发症发生率为40%;实验组患者30例患者中,电极脱位患者为1例,占3.33%、起搏器干扰患者为2例,占6.67%、电极导线断裂为1例,占3.33%,并发症发生率为13%。对比两组患者并发症发生率,差异显著(P<0.05)。结论:围手术期优质护理在改善永久性心脏起搏器植入术后感染患者疼痛方面,有非常显著的效果,值得在临床上推广应用。
作者 干星
出处 《健康之路》 2018年第10期207-207,共1页 Health Way
  • 相关文献

参考文献4

二级参考文献27

  • 1Epstein AE,DiMarco JP,Ellenbogen KA,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices):developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons[J]. Circulation,2008,17(21):e350-408.
  • 2Dickstein K, Vardas PE, Auricchio A,et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association[J]. Europace,2010,12(11): 1526-36.
  • 3Task Force Members,Brignole M,Auricchio A,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy:The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC)[J]. Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013 Jun 24. [Epub ahead of print].
  • 4Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins[J]. Acta Med Scand Suppl,1985,699:1-62.
  • 5Cabell CH,Heidenreich PA,Chu VH,et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999[J]. Am Heart J,2004,147(4):582-6.
  • 6Conklin EF,Giannelli S Jr,Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers[J]. J Thorac Cardiovasc Surg,1975,69(1):1-7.
  • 7Baddour LM,Bettmann MA,Bolger AF,et al. Nonvalvular cardiovascular device-related infections[J]. Circulation,2003,108(16):2015-31.
  • 8Baddour LM,Epstein AE,Erickson CC,et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American heart association[J]. Circulation, 2010, 121 (3):458-77.
  • 9Lin G,Meverden RA,Hodge DO,et al. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study[J]. J Interv Card Electrophysiol,2008,22(1):65-70.
  • 10Voigt A,Shalaby A,Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003[J].J Am Coil Cardiol,2006,48(3):590-1.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部